Funding agencies: This study was sponsored by the National Institutes of Health, National Institute of Neurological Disorders and Stroke.
Article first published online: 18 OCT 2012
Copyright © 2012 Movement Disorder Society
Volume 27, Issue 12, pages 1513–1521, October 2012
How to Cite
Elm, J. J. and The NINDS NET-PD Investigators (2012), Design innovations and baseline findings in a long-term Parkinson's trial: The national institute of neurological disorders and stroke exploratory trials in Parkinson's Disease Long-Term Study–1. Mov. Disord., 27: 1513–1521. doi: 10.1002/mds.25175
Relevant conflicts of interest/financial disclosure: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 18 OCT 2012
- Article first published online: 18 OCT 2012
- Manuscript Accepted: 31 JUL 2012
- Manuscript Revised: 19 JUN 2012
- Manuscript Received: 14 FEB 2012
This article has been cited by:
- 1Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease, Redox Biology, 2014, 2, 82, , ,
- 3Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease, Neurotherapeutics, 2014, 11, 1, 6, , ,
- 4The influence of age and gender on motor and non-motor features of early Parkinson's disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort, Parkinsonism & Related Disorders, 2014, 20, 1, 99, , , , , , ,
- 5Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases, Molecular and Cellular Neuroscience, 2013, 55, 101, ,
- 6Mitochondrial dysfunction and oxidative stress in Parkinson's disease, Progress in Neurobiology, 2013, 106-107, 17, ,